June 12, 2020 / 9:04 PM / a month ago

BRIEF-Azurrx Biopharma Inc - On June 11 Received Notice Of Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

June 12 (Reuters) - AzurRx BioPharma Inc:

* AZURRX BIOPHARMA INC - ON JUNE 11 RECEIVED NOTICE OF FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ Source text for Eikon: bit.ly/2YyFkmW Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below